NDC 0143-9682-01 - Glycopyrrolate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9682
- Requested NDC
- 0143-9682-01
- Package NDCs from labels
- 0143-9682-01, 0143-9682-25
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-06-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glycopyrrolate - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| GLYCOPYRROLATE INJECTION | Henry Schein, Inc. | 2025-08-18 | HUMAN PRESCRIPTION DRUG LABEL |
| GLYCOPYRROLATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| GLYCOPYRROLATE INJECTION, USP Rx ONLY NOT FOR NEONATES CONTAINS BENZYL ALCOHOL | General Injectables and Vaccines, Inc. | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| WATER - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2022-03-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9682-01 | Glycopyrrolate | 1 mL in 1 VIAL | INJECTION | 1 | 6 | |
| 0143-9682-25 | Glycopyrrolate | 25 in 1 CARTON | INJECTION | 25 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9682-01 | ML - Milliliter | 0143-9682 | b00d3e57-bba5-4ffd-b8c0-e59298a4cdb9 | 1 | 2013-09-04 |
| 0143-9682-25 | ML - Milliliter | 0143-9682 | 8f2ace03-ca90-4bfc-a8ad-28a026e1598a | 1 | 2013-09-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| GLYCOPYRRONIUM | ACTIVE MOIETY | A14FB57V1D | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 | |
| GLYCOPYRRONIUM | ACTIVE MOIETY | A14FB57V1D | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | GLYCOPYRROLATE INJECTION [CARDINAL HEALTH] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f126596-7fbf-7a48-e053-2995a90abac7 | 2023-05-15 | Warnings, Adverse reactions | 238212 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 8f12016d-9033-00b4-e053-2a95a90ad02a | 2023-05-15 | Warnings, Adverse reactions | 1731582 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9c9666bf-841b-03fa-e053-2a95a90abb48 | 2023-05-11 | Warnings, Adverse reactions | 1731582 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9e5113b7-1c0c-24bd-e053-2995a90ab94b | 2023-05-09 | Warnings, Adverse reactions | 238212 V92SO9WP2I |
| Sterile Water | STERILE WATER | Hikma Pharmaceuticals USA Inc. | b20a28b0-7dfa-42eb-9177-ec256d5a5ef7 | 2023-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | bbf0abe2-8deb-19b2-e053-2a95a90a60a3 | 2023-05-08 | Warnings, Adverse reactions | 1731582 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | b622f21f-fa37-1259-e053-2995a90aa796 | 2023-05-04 | Warnings, Adverse reactions | 1731582 V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | a2a2a03f-21cc-5fec-e053-2995a90a84cb | 2023-05-03 | Warnings, Adverse reactions | 1731582 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | LGM PHARMA SOLUTIONS, LLC | 392a969d-1e14-4ad8-835c-a47be4983067 | 2023-04-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | e8bb95ed-09f1-fcf1-e053-2a95a90a93e5 | 2023-04-25 | Warnings, Adverse reactions | 238212 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | ea4c8be4-a1e9-5901-e053-2995a90a5e63 | 2023-04-24 | Warnings, Adverse reactions | 238212 V92SO9WP2I |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| BEVESPI AEROSPHERE | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | ae02436e-9528-490e-a844-0c0f6f2843f9 | 2023-03-24 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Civica, Inc. | 3ac4f32f-f5ca-4a6d-9bc7-2672d478b3d4 | 2023-03-01 | Warnings, Adverse reactions | 1731582 V92SO9WP2I |
| NOVOLOG | INSULIN ASPART | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Acidum Muriaticum | ACIDUM MURIATICUM | Hahnemann Laboratories, INC. | f2aad04c-5151-6cab-e053-2a95a90ad3a7 | 2023-01-19 | QTT17582CB | |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02f914a8-2356-4525-91ff-cf0c9e41ba23 | 2023-01-12 | Warnings, Adverse reactions | 1731582 1731590 238212 V92SO9WP2I |
| Rehydrate | AVENA SATIVA, EQUISETUM HYEMALE, HYPERICUM PERFORATUM, ULMUS FULVA, GLYCYRRHIZA GLABRA, SILICEA, PUERARIA LOBATA, CARLSBAD AQUA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, GERMANIUM SESQUIOXIDE, HYDROGEN, OXYGEN, WIESBADEN | ParaDocs All Natural, Inc. | 648fab10-c46b-420f-a42c-6642009d83fb | 2023-01-10 | Warnings | 059QF0KO0R |
| 19ade311-5b73-493c-87ff-bec52d08c515 | ac6faa40-8a41-448d-ab41-3ba8551fca72 | 2022-12-22 | Warnings, Adverse reactions | 19ade311-5b73-493c-87ff-bec52d08c515 ac6faa40-8a41-448d-ab41-3ba8551fca72 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.